The 4008S Next Generation has been developed to provide safety and efficiency for all important treatment modalities within the scope of renal replacement therapies.
Description
In Stock
Features of this product
Monitoring of dialysis dose by OCM® (Online clearance monitoring and plasma sodium measurement)
Treatment with ultrapure dialysis fluid (DIASAFE®plus filter)
Use of hygienic, dry bicarbonate concentrate (Bibag®)
Single-needle method
Connection for central concentrate supply
Features of this product
Monitoring of dialysis dose by OCM® (Online clearance monitoring and plasma sodium measurement)
Treatment with ultrapure dialysis fluid (DIASAFE®plus filter)
Use of hygienic, dry bicarbonate concentrate (Bibag®)
Customers: Red Cross, Peter MacCallum Cancer, Royal Adelaide
Trade With Confidence. The supplier of this item is approved as a Verified Supplier. Business registration, contact details and locations have been verified. Fresenius Medical Care Australia are also proudly displaying these credentials: